BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25135991)

  • 41. Surveillance following orchidectomy for stage I seminoma of the testis.
    von der Maase H; Specht L; Jacobsen GK; Jakobsen A; Madsen EL; Pedersen M; Rørth M; Schultz H
    Eur J Cancer; 1993; 29A(14):1931-4. PubMed ID: 8280484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surveillance in stage I testicular seminoma - risk of late relapse.
    Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
    Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence-based guidelines for following stage 1 seminoma.
    Martin JM; Panzarella T; Zwahlen DR; Chung P; Warde P
    Cancer; 2007 Jun; 109(11):2248-56. PubMed ID: 17437287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
    Hallemeier CL; Pisansky TM; Davis BJ; Choo R
    Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical stage I testis cancer: long-term outcome of patients on surveillance.
    Sogani PC; Perrotti M; Herr HW; Fair WR; Thaler HT; Bosl G
    J Urol; 1998 Mar; 159(3):855-8. PubMed ID: 9474168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
    Tyrrell HEJ; Church DN; Joseph J; Traill ZC; Sullivan ME; Tuthill MH; Verrill CL; Pintus EP; Dallas NL; Rogers PB; Redgwell J; Protheroe AS
    Clin Genitourin Cancer; 2018 Jun; 16(3):240-244. PubMed ID: 29336917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Evolving Management of Patients With Clinical Stage I Seminoma.
    Matulewicz RS; Oberlin DT; Sheinfeld J; Meeks JJ
    Urology; 2016 Dec; 98():113-119. PubMed ID: 27527410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results.
    De Felice F; Musio D; Gravina GL; Marampon F; Tombolini V
    Oncotarget; 2016 Nov; 7(48):80077-80082. PubMed ID: 27556300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surveillance in stage I seminoma patients: a long-term assessment.
    Cummins S; Yau T; Huddart R; Dearnaley D; Horwich A
    Eur Urol; 2010 Apr; 57(4):673-8. PubMed ID: 19545941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of stage II seminoma.
    Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
    J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
    Joffe JK; Cafferty FH; Murphy L; Rustin GJS; Sohaib SA; Gabe R; Stenning SP; James E; Noor D; Wade S; Schiavone F; Swift S; Dunwoodie E; Hall M; Sharma A; Braybrooke J; Shamash J; Logue J; Taylor HH; Hennig I; White J; Rudman S; Worlding J; Bloomfield D; Faust G; Glen H; Jones R; Seckl M; MacDonald G; Sreenivasan T; Kumar S; Protheroe A; Venkitaraman R; Mazhar D; Coyle V; Highley M; Geldart T; Laing R; Kaplan RS; Huddart RA;
    J Clin Oncol; 2022 Aug; 40(22):2468-2478. PubMed ID: 35298280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stage I testicular seminoma risk-adapted therapeutic management.
    Mrinakova B; Kajo K; Lehotska V; Ondrusova M; Balogova S; Pinakova Z; Novotna V; Usakova V; Fedorkova L; Waczulikova I; Kausitz J; Ondrus D
    Neoplasma; 2021 May; 68(3):613-620. PubMed ID: 33502887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
    Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
    Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
    Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
    Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
    Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
    BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.